Select Medical Financials

Select Medical (SEM) reported $5.5B in total revenue for fiscal year 2025. This represents a 5.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Select Medical (SEM) revenue grew by 5.1% year-over-year, from $5.2B to $5.5B in fiscal year 2025.

Yes, Select Medical (SEM) reported a net income of $146.2M in fiscal year 2025, with a net profit margin of 2.7%.

Select Medical (SEM) reported diluted earnings per share of $1.16 for fiscal year 2025. This represents a -30.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Select Medical (SEM) had EBITDA of $476.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Select Medical (SEM) had $26.5M in cash and equivalents against $1.8B in long-term debt.

Select Medical (SEM) had a gross margin of 11.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Select Medical (SEM) had an operating margin of 6.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Select Medical (SEM) had a net profit margin of 2.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Select Medical (SEM) paid $0.25 per share in dividends during fiscal year 2025.

Select Medical (SEM) has a return on equity of 8.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Select Medical (SEM) generated $117.2M in free cash flow during fiscal year 2025. This represents a -60.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Select Medical (SEM) generated $346.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Select Medical (SEM) had $5.9B in total assets as of fiscal year 2025, including both current and long-term assets.

Select Medical (SEM) invested $229.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Select Medical (SEM) spent $100.1M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Select Medical (SEM) had 124M shares outstanding as of fiscal year 2025.

Select Medical (SEM) had a current ratio of 1.04 as of fiscal year 2025, which is considered adequate.

Select Medical (SEM) had a debt-to-equity ratio of 1.06 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Select Medical (SEM) had a return on assets of 2.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Select Medical (SEM) has an Altman Z-Score of 1.65, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Select Medical (SEM) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Select Medical (SEM) has an earnings quality ratio of 2.37x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Select Medical (SEM) has an interest coverage ratio of 2.9x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Select Medical (SEM) scores 39 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.